News round-up for 5-9 October, 2026 by Megan Thomas, Multimedia Editor at DDW. This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Conference in London, as well as some promising updates in cancer research and immunotherapy, particularly the development of new treatments and how… Read More
DDW has announced the full agenda for its Drug Discovery Innovators & Investors (DDII) London, UK Conference – a full-day, in-person event focused on early-stage drug discovery and development. This event is unique in its focus on early-stage drug discovery and development. From groundbreaking science and technology to regulation, funding and partnership, DDII… Read More
o2h co-discovery has announced that the Cambridge and London Life Sciences Showcase will return for its second edition during JP Morgan Healthcare Week 2027 in San Francisco. The event provides emerging companies with an international platform to present their science, innovation and growth opportunities directly to investors,… Read More
R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More
The full scientific programme for the 2026 ‘From Insight to Decision’ e-symposium, which is taking place on 2 and 8 December, has been announced by CN Bio. The event will feature expert-led sessions offering practical, real-world guidance on organ-on-a-chip (OOC) use within existing R&D strategies. Launched in… Read More
The pharmacological behaviour of drugs is determined not only by their intrinsic properties but also by the sensitivity of the biological systems in which they are evaluated. Variations in receptor density and signal transduction efficiency can significantly influence observed drug responses, complicating the translation of in vitro findings to in… Read More
Scientists have successfully used a drug to prolong the lifespan of several species of animals, in some cases by more than 25%. The study, published in Aging Cell, found strong evidence that triggering a protein, governing energy levels, may help organisms live significantly longer. … Read More
Nuclera has appointed Carl Raimond as Chief Executive Officer, effective immediately. Dr Michael Chen, Nuclera’s Co-founder and former CEO, transitions to the role of Chief Scientific and Business Officer, continuing to provide scientific leadership while supporting market development and strategic partnerships. The leadership transition reportedly marks the… Read More
Researchers at the Francis Crick Institute, King’s College London and Complutense University of Madrid have shown that γδ T cells use adaptive immune receptors to drive rapid, innate-like responses to tissue stress, inflammation and cancer. Researchers have long divided the immune system into two broad arms: innate… Read More
In this paid-for advertorial for the Fall 2026 issue of DDW, Sampled shares insight on neurological disease with a genomics and multiomics lens. Genomic testing can identify drivers of neurological disease, but many variants remain difficult to interpret. Multiomics helps to close this gap by connecting genetic findings with… Read More
This digital summit, hosted by DDW and supported by Sino Biological, explores the advances and challenges taking place within the field of immuno-oncology. It will take place on Wednesday, October 21, 2026 at 7am PDT / 10am EDT / 3pm BST / 4pm CEST. Featuring expert presentations and a panel… Read More
News round-up for 28 September – 2 October 2026 by Megan Thomas, Content Team at DDW. This week’s news roundup covers the upcoming the Drug Discovery Innovators & Investors Conference in London, as well as global updates on cancer research. The top stories: In-person… Read More
Results of an investigators’ Phase II clinical trial in vitamin C have been published by Wiley online in Cancer, a peer-reviewed journal of the American Cancer Society. Vitamin C boosts the activity of cellular proteins called TET enzymes that help control which genes are turned on or off. Because decreased… Read More
In his editorial comment for the Fall 2026 issue of DDW, Editor Reece Armstrong discusses innovation, investment, and how these come together in the Drug Discovery Innovators & Investors (DDII) event series. In my time with DDW, I’ve learned first-hand about the challenges drug discovery and development… Read More
The number of newly diagnosed classical Hodgkin lymphoma cases across the US, France, Germany, Italy, Spain, the UK, Japan and China (8MM) is expected to rise from 27,000 in 2025 to 28,000 by 2035, according to GlobalData. The company’s latest report, Hodgkin Lymphoma: Epidemiology Report and Forecast, projects an annual… Read More
R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More
